Cannapharm Technologies Malta Competitors and Similar CompaniesClear all
Cannapharm Technologies Malta's competitors and similar companies include Avicanna, AXIM Biotechnologies, CBDepot and BOL Pharma.
 Cannapharm Technologies Malta Cannapharm Technologies Malta (CPTM) is a company producing a variety of pharmaceutical, cosmetics, and cannabis-based products. |  Avicanna Avicanna is a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products. |  AXIM Biotechnologies AXIM Biotechnologies is a company focused on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. |  CBDepot BDepot is a company that supplies natural cannabinoids and cannabidiol-enriched products for the industrial and B2B markets. |  BOL Pharma BOL Pharma is a company that offers cannabinoid related products and active pharmaceutical ingredients (APIs) to the pharmaceutical industry. | |
Founding Date | Founding Date 2018 | Founding Date 2016 | Founding Date 2010 | Founding Date 2014 | Founding Date 2007 |
Type | Type Private | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations HQ | Locations Toronto, CA HQ | Locations New York, US HQ San Diego, US | Locations Teplice, CZ HQ | Locations Revadim, IL HQ |
Employees | Employees 350% increase | Employees 87 | Employees 6 | Employees 2 | Employees 343% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 23.9 m | Valuation ($) 1.5 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $25.5m (FY, 2025) | Revenue (est.) $39.5k (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $3.5m (FY, 2018) |
Cost of goods | Cost of goods N/A | Cost of goods $11.7m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods $5.8m (FY, 2018) |
Gross profit | Gross profit N/A | Gross profit $13.7m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit ($2.3m) (FY, 2018) |
Net income | Net income N/A | Net income ($2.8m) (FY, 2025) | Net income ($8.1m) (FY, 2023) | Net income N/A | Net income ($29.4m) (FY, 2018) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 1.2m | Total funding raised $ 115k | Total funding raised N/A | Total funding raised $ 2.9m |
For sources of this data, please see the company profile
View Company Profiles
Avicanna
HQ
Toronto, CA
Employees
87
Avicanna is a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products.
View companyAXIM Biotechnologies
HQ
New York, US
Employees
6
AXIM Biotechnologies is a company focused on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products.
View companyCBDepot
HQ
Teplice, CZ
BDepot is a company that supplies natural cannabinoids and cannabidiol-enriched products for the industrial and B2B markets.
View companyBOL Pharma
HQ
Revadim, IL
Employees
34↓ 3% decrease
BOL Pharma is a company that offers cannabinoid related products and active pharmaceutical ingredients (APIs) to the pharmaceutical industry.
View company